U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids. The Food and Drug Administration approved the pill from Vertex ...

Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' (VRTX.O), opens new tab drug to treat acute pain, the health regulator said on Thursday, offering a ...

The chiastic pattern I’d come to love in Scripture also shows up in God’s design for aging. As a self-professed Bible nerd and a lover of symmetry, no discovery has made me happier than that ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

1 Day VRTX -0.71% DJIA 0.38% S&P 500 0.53% Health Care/Life Sciences 0.19% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

The bank reported fresh slippages of Rs 5,432 crore, up 46 per cent YoY and 22.25 per cent sequentially ...

1. Current NAV: The Current Net Asset Value of the Axis Midcap Fund as of Jan 31, 2025 is Rs 102.82 for Growth option of its Regular plan. 2. Returns: Its trailing returns over different time periods ...

After hours: January 24 at 7:49:33 p.m. EST ...